Board of Directors
This section provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Investor information is released in Swedish for regulatory reasons and translated into English on a report-to-report basis. Please contact Redsense for additional information.
Eva Walde
Chairman of the Board, since 2024, member of the board since 2023
Professional background
Eva has over 30 years of experience in senior positions in pharmaceuticals, medical devices, diagnostics and biotechnology industries, mainly in marketing and sales. Most recently, Eva was VP Global Marketing at Olink Proteomics AB. She was elected into the board in May 2023 and in Dec 2023 she was appointed Chairman of the Board.
Education
Master of Science in Business and Economics from Gothenburg University.
Other assignments
Board member of Sedana Medical AB, Senzime AB, FrostPharma AB, Epigencia AB and board member, partner and investor in Life Science Invest.
Shares in Redsense Medical
No shares
Independent
Independent in relations to the Company, its management and the larger shareholders.
Susanne Olauson
Member of the Board, since 2013
Professional background
Susanne has over 25 years of sales experience in the pharmaceutical industry, the medical technology industry, and life science. This includes positions as VP of Commercial Operations, European Congress Manager, Director of Sales & Marketing Development and Product Specialist.
Education
Bachelor in Marketing from Växjö University.
Other assignments
Chairman of the Board at Odinwell AB (publ.), board member of LiU invest AB, Sangair AB, Red one & Red two AB.
Shares in Redsense Medical
3 000 shares
Non independent
As a major owner in Patrik Byhmer’s estate, Susanne is the largest shareholder and there for non-independent.
Malin Almgren
Member of the Board, since 2023
Professional background
Malin has over 20 years of
experience in the research field. She has worked for over two decades at esteemed institutions such as Karolinska Institutet and UCSD, gaining expertise in various fields like genetics/epigenetics, immunology, neuroscience and oncology. Her experience also includes working on clinical trials and collaborations with the industy. Aside from her scientific expertise, she has also developed a second career within finance. She has worked as a financial advisor for M&A transactions in the healthcare sector.
Education
Master in Biochemistry and a PhD in Medical Science.
Other assignments
CEO of Schain Research AB and board member of Experia Nordic Oy and Combigene AB.
Shares in Redsense Medical
No shares
Independent
Independent in relations to the Company, its management and the larger shareholders.
Lena Oswald
Member of the Board, since 2023
Professional background
Lena has a strategic profile with a focus on building and developing companies commercially and internationally. Thirty years of experience and ability to position companies, brands, develop assortments and sales channels and markets globally. She is specialized in the connection between business strategy, organization and people. Lena combines a holistic view, from the outside in perspective, with implementation and action.
Education
Master in International Business and Economics from Lund University.
Other assignments
Executive Chairman of Bolon, Chairman of Form Us With Love, Chairman of InterPares
Shares in Redsense Medical
No shares
Independent
Independent in relations to the Company, its management and the larger shareholders.
Martin Roos
Member of the Board, since 2024
Professional background
Martin Roos is an INSEAD certified board director (IDP) with board and executive experience from telecom, tech and biotech. Previously Martin has served on the Board Operating Committee of WOM in Chile, and was the CEO for Cable and Wireless Caribbean and Altice in the Dominican Republic (integrating Orange with Tricom), in addition to senior leadership positions with Ericsson. During his tenure at Cable and Wireless, Martin also served on the Board of Directors of TSTT in Trinidad and Tobago.
Education
MSc in Economics from Stockholm School of Economics. MSc in Chemical Engineering from The Royal Institute of Technology in Stockholm.
Other assignments
Chairman for Seamless Distribution Systems and board member of Nexam Chemicals (both listed on NGM and Nasdaq First North respectively). Martin also serves on the board of startups such as Lignin Industries (bioplastics from wood).
Shares in Redsense Medical
14 500 shares
Independent
Independent in relations to the Company, its management and the larger shareholders.